Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)
Koshizaka, Masaya, Ishikawa, Ko, Ishibashi, Ryoichi, Maezawa, Yoshiro, Sakamoto, Kenichi, Uchida, Daigaku, Nakamura, Susumu, Yamaga, Masaya, Yokoh, Hidetaka, Kobayashi, Akina, Onishi, Shunichiro, KobaJournal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13750
Date:
April, 2019
File:
PDF, 459 KB
2019